NanoViricides Inc. (NNVC)

[winstreak]

I say 2.

Since Nanoviricides informed us they intend to get into a rhythm of a new drug in human trials every six months, I figure two will do.

I expect 1 drug in the first year or maybe first two years, then as they improve their knowledge of procedures, processes, experience, and supply chains; they'll get their ducks in a row and get two in per year.

Remember, they are working on getting a platform approved that will make each drugs approval that much easier. I suggest even a unique path through FDA approval may be established when all the dust settles due to the "cookie cutter" manner in which these drugs are created. Similar to the way flu vaccines are done each year, perhaps.